Literature DB >> 3871149

Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography.

S Hussain, A Belldegrun, S E Seltzer, J P Richie, R F Gittes, H L Abrams.   

Abstract

CT findings in 43 adrenal masses were analyzed to see which features correlated most significantly with malignancy. Size, contrast enhancement, and consistency emerged as important discriminators of malignant from benign adrenal masses. These three factors were further analyzed by logistic regression technique to examine the joint influence of computed tomographic (CT) features in prediction of malignancy. As a result of logistic regression analysis, a table of estimated probability of malignancy as a function of tumor size alone and another table of estimated probability as a joint function of size and contrast enhancement were developed. Given a similar patient sample and by using the data given, it would be possible to predict chances of malignancy in an adrenal mass if its CT features are known; for example, a 5-cm adrenal mass without enhancement has a 0.31 probability of malignancy; with enhancement, a 0.68 probability.

Entities:  

Mesh:

Year:  1985        PMID: 3871149     DOI: 10.2214/ajr.144.1.61

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

1.  Adrenal incidentalomas: what is the role of fine needle biopsy?

Authors:  F Gaboardi; M Carbone; A Bozzola; L Galli
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?

Authors:  C Pohlink; A Tannapfe; U Eichfeld; F Schmidt; D Führer; R Paschke; C A Koch
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 3.  Surgical management of adrenocortical tumours.

Authors:  Barbra S Miller; Gerard M Doherty
Journal:  Nat Rev Endocrinol       Date:  2014-03-18       Impact factor: 43.330

Review 4.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

5.  Scintigraphy of incidentally discovered bilateral adrenal masses.

Authors:  M D Gross; B Shapiro; I R Francis; R L Bree; M Korobkin; M K McLeod; N W Thompson; J A Sanfield
Journal:  Eur J Nucl Med       Date:  1995-04

6.  Surgically resected adrenal leiomyoma: report of a case.

Authors:  S Nishida; A Tanimura; S Takasaki; S Nagaoka; M Fukueda; S Ikeda; K Matsuo; M Akao; M Tokunaga
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.

Authors:  Sung Hee Park; Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

8.  The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses.

Authors:  M Nakajo; Y Nakabeppu; R Yonekura; S Iwashita; T Goto
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

9.  Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index.

Authors:  H Miyake; H Takaki; S Matsumoto; S Yoshida; T Maeda; H Mori
Journal:  Abdom Imaging       Date:  1995 Nov-Dec

10.  Dexamethasone-suppressible feminizing adrenal adenoma.

Authors:  M Paja; S Díez; T Lucas; A Ojeda; L Salto; J Estrada
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.